Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: A case-control study

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 3, 1998, Pages 253-256

  Einarsson, Sigurdur ^a   Kristjansson, Mar ^a   Kristinsson, Karl G ^b   Kjartansson, Gudbrandur ^b   Jonsson, Steinn ^a  

^a Reykjavik City Hospital   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG COST; FEMALE; HEALTH CARE COST; HOSPITAL COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; PNEUMONIA; SEROTYPE; SMOKING;

ADULT; AGED; ANTI-BACTERIAL AGENTS; APACHE; CASE-CONTROL STUDIES; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; ICELAND; MALE; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 0031708359     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850160882     Document Type: Article

References (24)

1. Austrian R. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis 1981; 3: S1-S17.
2. Kislak JW, Razavi LMB, Daly AK, Finland M. Susceptibility of pneumococci to nine antibiotics. Am J Med Sci 1965; 250: 261-8.
3. Hofman J, Cetron M, Farley MM, Baugham WS, Facklam RR, Elliott JA, Deaver KA, Breiman RF. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333: 481-6.
4. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77-83.
5. Kristinsson KG. Hjalmarsdottir MA. Steingrimsson O. Increasing penicillin resistance in pneumococci in Iceland (Letter). Lancet 1992; 339: 1606-7.
6. Kristinsson KG. Epidemiology and penicillin resistant pneumococci in Iceland. Microbial Drug Resist 1995; 1: 121-5.
7. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168: 158-63.
8. Murray PR, Washington JA II. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clinic Proc 1975; 50: 339-44.
9. Martin RS, Sumarah RK, Robart EM. Assessment of expectorated sputum for bacteriological analysis based on polymorphism and squamous epithelial cells: six-month study. J Clin Microbiol 1978; 8: 635-7.
10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classifications system. Crit Care Med 1985; 13: 818-29.
11. Ruoff KL. Streptococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 6th edn. Washington, DC: ASM Press, 1995: 299-307.
12. Woods GL, Washington JA. Antimicrobial susceptibility tests: dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 6th edn. Washington. DC: ASM Press, 1995: 1327-41.
13. Kronwall G. A rapid slide-agglutination method for typing pneumococci by means of specific antibody adsorbed to protein-A-containing staphylococci. J Med Microbiol 1973; 6: 187-90.
14. Friedland IR, Klugman KP, Antibiotic-resistant pneumonococcal disease in South African children. Am J Dis Child 1992; 146: 920-3.
15. Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F. Resistance to penicillin and cephalosporin and morlality from severe pneumonococcal pneumonia in Barcelona. Spain. N Fngl J Med 1995; 333: 474-80.
16. Gillespie SH. Aspects of pneumococcal infection including bacterial virulence, host response and vaccination. J Med Microbiol 1989; 28: 237-48.
17. Austrian R. The enduring pneumococcus: unfinished business and opportunities for the future. Microbial Drug Resist 1997; 3: 111-2.
18. Linares J, Pallares R, Alonso T, Perez JL, Ayats J, Gudiol F, Viladrich PF, Martin R. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona. Spain (1979 1990). Clin Infect Dis 1992; 15: 99-105.
19. Bédos J-P, Chevret S, Chanstang C, Geslin P. Régnier B. French Cooperative Pneumococcus Study Group. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin Infect Dis 1996; 22: 63-72.
20. Pallares R, Gudiol F, Linares J, Ariza J, Rufi G, Murgui L, Dorca J, Viladrich PF. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987; 317: 18-22.
21. Arason VA, Kristinsson KG, Sigurdsson JA, Stefansdottir G, Molstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996; 313: 387-91.
22. Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona. Spain. N Engl J Med 1995; 333: 474-80.
23. Friedland IR, McCracen GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994; 331: 377-82.
24. Goldstein FW, Garau J. Resistant pneumococci: a renewed threat in respiratory infections. Scand J Infect Dis 1994; Suppl 93: 55-62.